The Bill & Melinda Gates Foundation has invested tens of millions in German biotech firm CureVac.
The cash injection will help the company continue working on developing effective vaccines for diseases including Ebola, HIV and tuberculosis.
The Democratic Republic of Congo has given the green light to an experimental vaccine to combat an ongoing Ebola outbreak. While the vaccine is not licensed, it has shown promising signs in a clinical trial.
After helplessly watching 11,000 Ebola patients die in 2014, the World Health Organization now introduces a vaccine against the virus. It was developed by the Canadian government and is licensed to Merck.
A prototype vaccine for Ebola has proven effective in Guinea, according to the World Health Organization. It hopes fast-track approval will emerge by 2018. The hemorrhagic virus killed 11,300 people in western Africa.
© 2017 Deutsche Welle |
Legal notice |